Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Amoxapine

Amoxapine: 1 brand, 6 generics; first approved May 11, 1989; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 6 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
6
Listed patents
0
Presentations
16

Brand (NDA) products

Originator applications
Ask AI
  • NDA 018021-4 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGTABLETORALDiscontinued-
    50MGTABLETORALDiscontinued-
    100MGTABLETORALDiscontinued-
    150MGTABLETORALDiscontinued-

Generic (ANDA) products (6)

Abbreviated applications
Ask AI
  • AMOXAPINE
    ANDA 07269119924 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    150MGTABLETORALRxAB
    25MGTABLETORALRxAB
    50MGTABLETORALRxAB
    100MGTABLETORALRxAB
  • AMOXAPINE
    ANDA 07287919914 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    150MGTABLETORALRxAB
    25MGTABLETORALRxAB
    50MGTABLETORALRxAB
    100MGTABLETORALRxAB
  • AMOXAPINE
    ANDA 0724181989
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGTABLETORALDiscontinued-
  • AMOXAPINE
    ANDA 0724191989
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MGTABLETORALDiscontinued-
  • AMOXAPINE
    ANDA 0724201989
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    100MGTABLETORALDiscontinued-
  • AMOXAPINE
    ANDA 0724211989
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    150MGTABLETORALDiscontinued-

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
38 yr 1 mo ago
Most recent approval
34 yr 9 mo ago

Approvals span 1989–1992 across 7 FDA applications.

Brand (NDA) 114%
Generic (ANDA) 686%

Amoxapine: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Amoxapine

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo